University at Buffalo: Study - For Long COVID, Lithium Aspartate at Low Doses is Ineffective, But Higher Doses May Be Promising
October 03, 2024
October 03, 2024
BUFFALO, New York, Oct. 3 (TNSres) -- The University at Buffalo (State University of New York) issued the following news release:
* * *
UB researcher characterizes the findings published in JAMA Network Open as "a negative study with a positive twist"
* * *
A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature . . .
* * *
UB researcher characterizes the findings published in JAMA Network Open as "a negative study with a positive twist"
* * *
A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature . . .